Sign in
4

Changes in Ownership

PROVECTUS BIOPHARMACEUTICALS, INC. Filed Acc 0001140361-07-021598

Chief Financial Officer acquired 50,000 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

CULPEPPER PETER R · Chief Financial Officer

Table I: Non-derivative

1 line
Date Transaction Shares Price Value Owned after D/I
2007-11-12 Exercise or conversion : show line 1 in the form +50,000 $0.64 $32,000 215,581 D

Table II: Derivative

1 line
Date Transaction Shares Exercise Expires Underlying Owned after D/I
2007-11-12 Exercise or conversion : show line 2 in the form Stock Options (Right to buy) −50,000 $0.64 2015-01-07 50,000 150,000 D
Loading xslF345X02/doc1.xml…